Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Among authors: chamorro a. Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Cerebrovasc Dis. 2009. PMID: 19372653 Free article. Clinical Trial.
Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial.
Bogousslavsky J, Victor SJ, Salinas EO, Pallay A, Donnan GA, Fieschi C, Kaste M, Orgogozo JM, Chamorro A, Desmet A; European-Australian Fiblast (Trafermin) in Acute Stroke Group. Bogousslavsky J, et al. Among authors: chamorro a. Cerebrovasc Dis. 2002;14(3-4):239-51. doi: 10.1159/000065683. Cerebrovasc Dis. 2002. PMID: 12403958 Clinical Trial.
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Among authors: chamorro a. Cerebrovasc Dis. 2009;27(6):608-13. doi: 10.1159/000216835. Epub 2009 Apr 30. Cerebrovasc Dis. 2009. PMID: 19407444 Free article. Clinical Trial.
European Stroke Science Workshop.
Mattle HP, Brainin M, Chamorro A, Diener HC, Hacke W, Leys D, Norrving B, Ward N. Mattle HP, et al. Among authors: chamorro a. Cerebrovasc Dis. 2012;34(2):95-105. doi: 10.1159/000341728. Epub 2012 Jul 26. Cerebrovasc Dis. 2012. PMID: 22846653 Free article.
The scope of the workshop was to review the most recent findings of selected topics in stroke, to exchange ideas, to stimulate new research, and to enhance collaboration between European stroke research groups. Seven scientific sessions were held, each starting with a keyn …
The scope of the workshop was to review the most recent findings of selected topics in stroke, to exchange ideas, to stimulate new research, …
eTICI reperfusion: defining success in endovascular stroke therapy.
Liebeskind DS, Bracard S, Guillemin F, Jahan R, Jovin TG, Majoie CB, Mitchell PJ, van der Lugt A, Menon BK, San Román L, Campbell BC, Muir KW, Hill MD, Dippel DW, Saver JL, Demchuk AM, Dávalos A, White P, Brown S, Goyal M; HERMES Collaborators. Liebeskind DS, et al. J Neurointerv Surg. 2019 May;11(5):433-438. doi: 10.1136/neurintsurg-2018-014127. Epub 2018 Sep 7. J Neurointerv Surg. 2019. PMID: 30194109 Free article.
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators. Román LS, et al. Lancet Neurol. 2018 Oct;17(10):895-904. doi: 10.1016/S1474-4422(18)30242-4. Epub 2018 Sep 18. Lancet Neurol. 2018. PMID: 30264728 Free article.
495 results